Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 88 (PPIAP88) is classified as a **pseudogene**, which means it is a segment of DNA similar in sequence to the functional Peptidylprolyl isomerase A (PPIA) gene but is generally considered non-functional and does not encode a protein product[2][8]. Pseudogenes may be transcribed into RNA, but due to accumulated mutations such as frameshifts or premature stop codons, they lack the ability to produce a functional enzyme or receptor. Although some pseudogenes can regulate gene expression indirectly (for example, via microRNA decoy activity), there is currently no evidence that PPIAP88 itself serves as a therapeutic target, nor are there known drugs, biomarkers, or direct disease associations for this locus[2][8]. Therefore, it is not considered a therapeutic target. **Note:** - The abbreviation "PPIAP88" and the full name both refer specifically to a pseudogene, not to an active receptor, enzyme, or therapeutic target. - There is nothing to suggest that this entry refers to a misspelling or misidentification, but since it is a pseudogene and not a functional target, `is_incorrect` should be marked true for the context of therapeutic targeting. - All functional information about enzymatic activity, drug interactions, or disease relevance pertains to the functional PPIA gene (Cyclophilin A), not the PPIAP88 pseudogene[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 88 (PPIAP88).